Nancy E. Davidson, MD
Director, University of Pittsburgh Cancer Center; UPMC Cancer Centers Associate Vice Chancellor for Cancer Research; Hillman Professor of Oncology; Chief, Division of Hematology/Oncology; Professor of Medicine
University of Pittsburgh School of Medicine
Past President, American Society of Clinical Oncology (ASCO)
Member, BCRF Executive Board of Scientific Advisors
2009-2010:
After over 10 years of support from The Breast Cancer Research Foundation for breast cancer research at Johns Hopkins, Dr. Davidson moved to become Director of the University of Pittsburgh Cancer Institute on February 1, 2009 and the Davidson laboratory moved to the University of Pittsburgh Cancer Institute on May 18, 2009. Over the next year, work on epigenetic modifiers in breast cancer biology and therapy will continue in this new location and new opportunities for collaboration with Pitt investigators in breast cancer will be sought.
Mid-Year Progress Report:
Dr. Davidson reports two publications on her ongoing BCRF-funded studies since October 1. She also has initiated new work in DNA repair. Thanks to BCRF support studies have been initiated to evaluate the hypothesis that ATM kinase has a regulatory function in DNA repair that is essential for viability in cancer cells.
Bio:
Nancy Davidson received her MD in 1979 from Harvard Medical School in Boston, MA, and completed internal medicine training at the Hospital of the University of Pennsylvania and Johns Hopkins. Dr. Davidson was a Medical Staff Fellow and guest worker at the National Cancer Institute in Bethesda from 1982-86 where she developed a major interest in the breast cancer field. She joined the faculty at the Johns Hopkins University School of Medicine in 1986 as an Assistant Professor in Oncology.
Trained as a medical oncologist and scientist, Dr. Davidson has devoted her career to breast cancer research, in both the clinical and laboratory setting. Her clinical research has focused on the value of combination therapy with chemotherapy and hormonal therapy for young women with breast cancer. One of her major laboratory interests has been the definition of the biochemical pathways by which breast cancer cells die, in the hope that new targets for anti-breast cancer therapy can be identified as well as epigenetic regulation of gene expression.
In 2009, Dr. Davidson became Director of the University of Pittsburgh Cancer Institute.
|
